Company news

Vor Biopharma Inc. news in 2023

Vor Biopharma Inc.'s news releases, calls and decks from 2023, newest first.

View company

Vor Bio to Participate in the JMP Securities Hematology and Oncology Summit

November 26, 2023

Vor Bio Presents Positive Data Update on Trem-cel at HSCT² Conference

November 8, 2023

Vor Bio Reports Third Quarter 2023 Financial Results and Provides Company Update

November 6, 2023

Multiple Clinical and Preclinical Presentations at ASH 2023 Highlight Vor Bio’s Novel eHSC and CAR-T Platform

November 1, 2023

Vor Bio Reports Second Quarter 2023 Financial Results and Provides Company Update

August 9, 2023

Vor Bio to Participate in the Wedbush PacGrow Healthcare Conference

July 31, 2023

Successful Primary Engraftment of Trem-cel in First Five AML Patients Demonstrates Promise of Vor Bio’s Platform

June 8, 2023

Vor Bio to Participate in the Goldman Sachs Healthcare Conference

June 4, 2023

Vor Bio Reports First Quarter 2023 Financial Results and Provides Company Update

May 10, 2023

Vor Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Company Update

March 22, 2023

First AML Patient Transplanted with Vor Bio’s Trem-cel Demonstrated Durable Engraftment through Multiple Mylotarg™ Cycles at Initial Dose Level

February 15, 2023

Vor Bio to Present Clinical Data from First Patient Treated with Trem-cel at 2023 Tandem Meetings

January 18, 2023

Vor Bio to Present at B. Riley Securities’ 3rd Annual Oncology Conference

January 11, 2023

Decks in 2023